Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03786081
Title Safety and Efficacy of Tisotumab Vedotin in Combination With Other Cancer Agents in Subjects With Cervical Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Genmab
Indications

cervical adenosquamous carcinoma

cervical adenocarcinoma

cervical squamous cell carcinoma

Therapies

Bevacizumab + Tisotumab vedotin-tftv

Carboplatin + Tisotumab vedotin-tftv

Pembrolizumab + Tisotumab vedotin-tftv

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.